Electronic Spectacles Versus Low Dose Atropine in Young Myopes

NARecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Myopia
Interventions
DEVICE

eSpectacle Clinical prototype (CP1) device

The CP1 device consists of a clear 15° central aperture and projects +9.00D defocused micro-LED lights of approximately 4800 nits illumination to the peripheral retina.

DRUG

0.01% atropine

Atropine is a and anticholinergic medication which can be used for dilation and cycloplegia.

Trial Locations (1)

Unknown

RECRUITING

CMU Hsinchu Hospital, Hsinchu

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

China Medical University Hospital

OTHER

lead

Kubota Vision Inc.

INDUSTRY

NCT06034379 - Electronic Spectacles Versus Low Dose Atropine in Young Myopes | Biotech Hunter | Biotech Hunter